Vascular dementia (VaD) is the second major cause of dementia accounting for 15 to 20 per cent of all dementia cases. VaD is an acquired cognitive impairment due to multiple mini strokes, some of which may be undetectable to the patient.
The result is memory loss and a decline in cognitive ability.
Currently, viable pharmaceutical options are lacking.
If you’ve been diagnosed with either vascular dementia, or mixed Alzheimer’s and vascular dementia, NICM Health Research Institute researchers would like you to take part in their clinical trial.
Their study is investigating whether a standardised Chinese herbal medicine formula, Sailuotong (SLT), can help treat vascular dementia. Results of initial trials show promise in improving memory, learning and daily function.
Learn more about the study by visiting the NICM Health Research Institute website or downloading this flyer